PATENT CLAIM ANALYSIS

Application Number: 16146644
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "278000"]

Abstract:
The present disclosure provides a compound of Chemical Formula (1) or a pharmaceutically acceptable salt thereof, and a pharmaceutical composition comprising the same: wherein X, Z, R 1  and R 2  are as defined in the specification. The compound of Chemical Formula (1) or pharmaceutically acceptable salt thereof acts as a positive allosteric modulator of metabotropic glutamate receptor subtype 5 (mGluR5), thereby being useful in the prevention or treatment of disorder mediated by glutamate dysfunction and mGluR5.

Claim (Index 37):
The method of  claim 35 , wherein n is 1 or 2; each R 3  is selected from the group consisting of fluoro, fluoromethyl, trifluoromethyl, methyl, and hydroxymethyl; m is 0 or 1; and R 6  is fluoro.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.63636
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15664633', '15053569', '13516985', '15094687', '15962333']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8054124981623142
- 35 USC 102 Novelty (BERT): 0.625336387671118
- Combined Prediction Score: 0.7874048871131946
- Mean Citation Score: 412.195834
- Max Citation Score: 594.1443
- Similarity Product: 512.7728642885863

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test